{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T05:40:03Z","timestamp":1744522803987,"version":"3.40.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,12]]},"DOI":"10.7759\/cureus.82155","type":"journal-article","created":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T05:00:56Z","timestamp":1744520456000},"source":"Crossref","is-referenced-by-count":0,"title":["Identification of Hub Genes and Pathways in Preinfusion Chimeric Antigen Receptor (CAR) T-cell Products Associated With Cytokine Release Syndrome"],"prefix":"10.7759","author":[{"given":"Somia A","family":"Khalafallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Mohammed Elzein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israa M","family":"Faris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamila A","family":"Attaelmanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa F.","family":"Alamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Almleeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Alfaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June CH","year":"2018","unstructured":"June CH, O'Connor RS, Kawalekar OU, Ghassemi S, Milone MC. CAR T cell immunotherapy for human cancer. Science. 2018, 359:1361-5. 10.1126\/science.aar6711","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster SJ","year":"2019","unstructured":"Schuster SJ, Bishop MR, Tam CS, et al.. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N Engl J Med. 2019, 380:45-56. 10.1056\/NEJMoa1804980","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2018.11.002","article-title":"Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management","volume":"34","author":"Brudno JN","year":"2019","unstructured":"Brudno JN, Kochenderfer JN. Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management. Blood Rev. 2019, 34:45-55. 10.1016\/j.blre.2018.11.002","journal-title":"Blood Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.07.025","article-title":"Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies","volume":"146","author":"Freyer CW","year":"2020","unstructured":"Freyer CW, Porter DL. Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies. J Allergy Clin Immunol. 2020, 146:940-8. 10.1016\/j.jaci.2020.07.025","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy","volume":"130","author":"Hay KA","year":"2017","unstructured":"Hay KA, Hanafi LA, Li D, et al.. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy. Blood. 2017, 130:2295-306. 10.1182\/blood-2017-06-793141","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0041-7","article-title":"CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade","volume":"24","author":"Giavridis T","year":"2018","unstructured":"Giavridis T, van der Stegen SJ, Eyquem J, Hamieh M, Piersigilli A, Sadelain M. CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat Med. 2018, 24:731-8. 10.1038\/s41591-018-0041-7","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"6","author":"Teachey DT","year":"2016","unstructured":"Teachey DT, Lacey SF, Shaw PA, et al.. Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Cancer Discov. 2016, 6:664-79. 10.1158\/2159-8290.CD-16-0040","journal-title":"Cancer Discov"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells","volume":"7","author":"Gust J","year":"2017","unstructured":"Gust J, Hay KA, Hanafi LA, et al.. Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells. Cancer Discov. 2017, 7:1404-19. 10.1158\/2159-8290.CD-17-0698","journal-title":"Cancer Discov"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-828343","article-title":"Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL","volume":"132","author":"Rossi J","year":"2018","unstructured":"Rossi J, Paczkowski P, Shen YW, et al.. Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL. Blood. 2018, 132:804-14. 10.1182\/blood-2018-01-828343","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie ME","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015, 43:e47. 10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with bioconductor","volume":"12","author":"Huber W","year":"2015","unstructured":"Huber W, Carey VJ, Gentleman R, et al.. Orchestrating high-throughput genomic analysis with bioconductor. Nat Methods. 2015, 12:115-21. 10.1038\/nmeth.3252","journal-title":"Nat Methods"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2787-y","article-title":"A comprehensive analysis of candidate genes and pathways in pancreatic cancer","volume":"36","author":"Liu J","year":"2015","unstructured":"Liu J, Li J, Li H, Li A, Liu B, Han L. A comprehensive analysis of candidate genes and pathways in pancreatic cancer. Tumour Biol. 2015, 36:1849-57. 10.1007\/s13277-014-2787-y","journal-title":"Tumour Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov MV","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, et al.. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016, 44:W90-7. 10.1093\/nar\/gkw377","journal-title":"Nucleic Acids Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang D","year":"2023","unstructured":"Tang D, Chen M, Huang X, et al.. SRplot: a free online platform for data visualization and graphing. PLoS One. 2023, 18:e0294236. 10.1371\/journal.pone.0294236","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","article-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham H","year":"2016","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag, New York, NY; 2016. 10.1007\/978-3-319-24277-4"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk D","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, et al.. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019, 47:D607-13. 10.1093\/nar\/gky1131","journal-title":"Nucleic Acids Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon P","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, et al.. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13:2498-504. 10.1101\/gr.1239303","journal-title":"Genome Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296030","article-title":"Identification of the feature genes involved in cytokine release syndrome in COVID-19","volume":"19","author":"Yang B","year":"2024","unstructured":"Yang B, Pan M, Feng K, Wu X, Yang F, Yang P. Identification of the feature genes involved in cytokine release syndrome in COVID-19. PLoS One. 2024, 19:e0296030. 10.1371\/journal.pone.0296030","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8 Suppl 4","author":"Chin CH","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014, 8 Suppl 4:S11. 10.1186\/1752-0509-8-S4-S11","journal-title":"BMC Syst Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/ni1008-1091","article-title":"The Immunological Genome Project: networks of gene expression in immune cells","volume":"9","author":"Heng TS","year":"2008","unstructured":"Heng TS, Painter MW. The Immunological Genome Project: networks of gene expression in immune cells. Nat Immunol. 2008, 9:1091-4. 10.1038\/ni1008-1091","journal-title":"Nat Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1040","article-title":"DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms","volume":"52","author":"Cannon M","year":"2024","unstructured":"Cannon M, Stevenson J, Stahl K, et al.. DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms. Nucleic Acids Res. 2024, 52:D1227-35. 10.1093\/nar\/gkad1040","journal-title":"Nucleic Acids Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7137900","article-title":"Potential pathophysiological mechanisms underlying multiple organ dysfunction in cytokine release syndrome","volume":"2022","author":"Chen P","year":"2022","unstructured":"Chen P, Tang Y, He W, Yang R, Lan Z, Chen R, Zhang P. Potential pathophysiological mechanisms underlying multiple organ dysfunction in cytokine release syndrome. Mediators Inflamm. 2022, 2022:7137900. 10.1155\/2022\/7137900","journal-title":"Mediators Inflamm"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen A","year":"2018","unstructured":"Shimabukuro-Vornhagen A, G\u00f6del P, Subklewe M, et al.. Cytokine release syndrome. J Immunother Cancer. 2018, 6:56. 10.1186\/s40425-018-0343-9","journal-title":"J Immunother Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01301-7","article-title":"Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome","volume":"20","author":"Wei Y","year":"2021","unstructured":"Wei Y, Li C, Bian H, et al.. Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome. Mol Cancer. 2021, 20:5. 10.1186\/s12943-020-01301-7","journal-title":"Mol Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli M","year":"2018","unstructured":"Norelli M, Camisa B, Barbiera G, et al.. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat Med. 2018, 24:739-48. 10.1038\/s41591-018-0036-4","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1184703","article-title":"Research progress of interleukin-15 in cancer immunotherapy","volume":"14","author":"Cai M","year":"2023","unstructured":"Cai M, Huang X, Huang X, Ju D, Zhu YZ, Ye L. Research progress of interleukin-15 in cancer immunotherapy. Front Pharmacol. 2023, 14:1184703. 10.3389\/fphar.2023.1184703","journal-title":"Front Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2428","article-title":"Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy","volume":"22","author":"Picarda E","year":"2016","unstructured":"Picarda E, Ohaegbulam KC, Zang X. Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy. Clin Cancer Res. 2016, 22:3425-31. 10.1158\/1078-0432.CCR-15-2428","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02156","article-title":"Inhibitory receptors and checkpoints in human NK cells, implications for the immunotherapy of cancer","volume":"11","author":"Sivori S","year":"2020","unstructured":"Sivori S, Della Chiesa M, Carlomagno S, et al.. Inhibitory receptors and checkpoints in human NK cells, implications for the immunotherapy of cancer. Front Immunol. 2020, 11:2156. 10.3389\/fimmu.2020.02156","journal-title":"Front Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxu079","article-title":"CCR4 and its ligands: from bench to bedside","volume":"27","author":"Yoshie O","year":"2015","unstructured":"Yoshie O, Matsushima K. CCR4 and its ligands: from bench to bedside. Int Immunol. 2015, 27:11-20. 10.1093\/intimm\/dxu079","journal-title":"Int Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347404-identification-of-hub-genes-and-pathways-in-preinfusion-chimeric-antigen-receptor-car-t-cell-products-associated-with-cytokine-release-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T05:00:57Z","timestamp":1744520457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347404-identification-of-hub-genes-and-pathways-in-preinfusion-chimeric-antigen-receptor-car-t-cell-products-associated-with-cytokine-release-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.82155","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,12]]}}}